Skip to content

The Oncology Institute, Inc. TOI Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$30.28M-23.8%$33.57M-32.4%$27.66M-41.7%$30.29M-16.8%$39.74M+10.2%
$232.43M+12.7%$223.62M+3.7%$212.95M+1.6%$207.82M+2.1%$206.17M+5.2%
$75.83M+73.2%$63.85M+48.4%$57.02M+22.2%$48.24M-1.0%$43.78M-11.7%
$116.86M+9.4%$112.75M+0.3%$110.09M-5.4%$104.79M-9.8%$106.82M-24.3%
$10.7M-3.8%$10.68M-10.1%$10.71M-12.7%$10.85M-11.3%$11.12M+1.1%
$7.23M0.0%$7.23M0.0%$7.23M0.0%$7.23M0.0%$7.23M0.0%
$10.3M-26.6%$11.02M-25.6%$11.73M-24.7%$12.45M-23.9%$14.04M-18.1%
$168.23M+2.6%$164.66M-4.7%$163.62M-8.7%$159.8M-11.0%$164M-19.8%
$47.65M+62.7%$43.17M+77.5%$35.63M+45.0%$34.93M+122%$29.29M+39.4%
$79.35M+33.3%$70.96M+35.9%$65.58M+40.3%$64.78M+84.5%$59.54M+30.1%
$78.61M+6.4%$77.4M-16.9%$76.2M-16.8%$75.02M-16.6%$73.89M-16.4%
$184.52M+16.1%$180.38M+6.7%$175.89M+7.4%$168.78M+12.2%$158.93M-2.6%
500M0.0%500M+6,249,900%500M0.0%500M0.0%500M0.0%
-$273.91M-18.9%-$271.42M-28.7%-$263.91M-33.5%-$247.41M-36.3%-$230.4M-38.8%
-$16.29M-421%-$15.72M-538%-$12.27M-179%-$8.99M-131%$5.07M-87.7%
$168.23M+2.6%$164.66M-4.7%$163.62M-8.7%$159.8M-11.0%$164M-19.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are The Oncology Institute, Inc.'s total assets?
The Oncology Institute, Inc. (TOI) holds $168.2M in total assets, up 2.6% year over year.
How much debt does The Oncology Institute, Inc. have?
The Oncology Institute, Inc. carries $104.9M in total debt against -$16.3M of shareholders' equity, a debt-to-equity ratio of 20.21.
How much cash does The Oncology Institute, Inc. have?
The Oncology Institute, Inc. holds $30.3M in cash and equivalents.
Can The Oncology Institute, Inc. cover its short-term obligations?
Its current ratio is 1.47 — current assets exceed current liabilities.
Where does The Oncology Institute, Inc.'s balance sheet data come from?
Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.